Preview Mode Links will not work in preview mode

Nov 29, 2022

Featuring a slide presentation and related discussion from Dr Toni Choueiri, including the following topics:

  • Evolution in the management of renal cell carcinoma (RCC) (0:00)
  • Adjuvant therapy for intermediate- or high-risk RCC (1:52)
  • Front-line therapy for patients with metastatic RCC (8:39)
  • New agents for the treatment of relapsed or refractory RCC (16:24)
  • Mechanism of action and efficacy of HIF2-alpha inhibitors for von Hippel-Lindau-associated RCC (19:56)

CME information and select publications